BridgeMD
New treatment option for Major Depression
Official title Combining Light Therapy and CPAP in Depression
ClinicalTrials.gov ID: NCT06781593
What this study is testing
- What it's testing
- In a double-blind, parallel-group controlled trial, we aim to measure the effect of two weeks of light therapy combined with the CPAP on compliance CPAP in patients with major depressive disorder.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron
- Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15
- Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP.
You likely can't join if
- Refusal to participate.
- Pregnant and breast-feeding women
- Under guardianship or curatorship.
- Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators.
- Other psychiatric, neurologic or somatic conditions
- Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less...
See the full eligibility criteria
- Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron
- Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15
- Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP.
- Refusal to participate.
- Pregnant and breast-feeding women
- Under guardianship or curatorship.
- Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators.
- Other psychiatric, neurologic or somatic conditions
- Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less than 3 months). patient wishing to choose a provider other than the...
- Patient wishing to choose a device other than SEFAM's S-BOX or a mask other than the nasal mask at the time of introduction.
- Nasal obstruction.
- Refusal to use actimetry, refusal to use light therapy, refusal to use CPAP.
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France, France
- Bron, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France, France; Bron, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.